Synapse - Bone Marrow Transplant

Results (2969)

NKTR-255 vs placebo to enhance complete responses and durability following CD19-directed CAR-T therapy in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)

Meeting Abstract

Ahmed, S.; Dipersio, J. F.; Essell, J. H.; Diefenbach, C. S.; Perales, M. A.; Castilla-Llorente, C.; Dahiya, S.; Chaudhry, S.; Xu, H.; Liu, Y.; more...
Blood (2024)

Fulltext@MSK | Save

Effector differentiation and exhaustion attenuate on-target, off-tumor toxicity of CD24 CAR T cells

Meeting Abstract

Boardman, A. P.; Rajagopalan, A.; Chen, S.; Ng, B.; Fischman, J.; Massa, A.; Elias, H. K.; Manuele, D.; Atmane, M. I.; Miranda, I.; more...
Blood (2024)

Fulltext@MSK | Save

CD371-targeted CAR T-cells secreting interleukin-18 exhibit robust expansion and disease clearance in patients with refractory acute myeloid leukemia

Meeting Abstract

Geyer, M. B.; Dewolf, S.; Mi, X.; Shaffer, B. C.; Cadzin, B.; McAvoy, D.; Hosszu, K. K.; Weis, K.; Lorenc, R.; Lewis, A. M.; more...
Blood (2024)

Fulltext@MSK | Save

Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)

Meeting Abstract

Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
Blood (2024)

Fulltext@MSK | Save

Initial results from the ASH research collaborative's COVID-19 outcomes in myeloma and the impact of vaccines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections

Meeting Abstract

Usmani, S. Z.; Semmel, E. A.; James, S.; Wood, W. A.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; Zonder, J. A.; Rubinstein, S. M.; D'Souza, A.; more...
Blood (2024)

Fulltext@MSK | Save

Superiority of post-transplant cyclophosphamide-based graft versus host disease (GvHD) prophylaxis in patients 70 years and older: A BMT CTN 1703 post-hoc analysis

Meeting Abstract

Abedin, S.; Lian, Q. H.; Martens, M. J.; Malki, M. M. A.; Elmariah, H.; Gooptu, M.; Larkin, K. T.; Shaffer, B. C.; Loren, A. W.; Solh, M. M.; more...
Blood (2024)

Fulltext@MSK | Save

CAR-tography: Longitudinal mapping of CAR-T toxicities across B-cell malignancies reveals biologically distinct and prognostically relevant toxicity phenotypes

Meeting Abstract

Rejeski, K.; Fei, T.; Luna, A.; Alhomoud, M.; Valtis, Y. K.; Nishimura, N.; Gomez-Llobell, M.; Accav, N. G.; Beyar-Katz, O.; Raj, S. S.; more...
Blood (2024)

Fulltext@MSK | Save

Barriers to immune effector cell therapy: Rapid disease progression, concern for toxicity, and lack of appropriate trials drive non-receipt after referral at a large academic center

Meeting Abstract

Valtis, Y. K.; Chin, K. K.; Yisraeli Salman, M.; Boussi, L.; Cadzin, B.; McLoughlin, C.; Cathcart, E.; Davis, P.; Brooklyn, C.; Goldstein, T.; more...
Blood (2024)

Fulltext@MSK | Save

Prediction of post-transplant relapse of the myelodysplastic syndromes via evaluation of stem cells

Meeting Abstract

Kroger, B.; Tamari, R.; Gurnari, C.; Thiebaud, J. A.; Velarde, A. M.; Madanat, Y. F.; Collins, R. H.; Jackson, C.; Gatell, V. I.; Visconte, V.; more...
Blood (2024)

Fulltext@MSK | Save

Phase II study of longitudinal geriatric assessment with risk-adapted interventions to reduce non-relapse mortality in allogeneic hematopoietic cell transplantation for older patients with advanced myeloid malignancies

Meeting Abstract

Lin, R. J.; Kim, S. J.; Brown, S.; Hanley, D. M.; Engstler, D. E.; Politikos, I.; Gyurkocza, B.; Tamari, R.; Papadopoulos, E. B.; Saldia, A.; more...
Blood (2024)

Fulltext@MSK | Save